Posicor
On June 20, 1997, the FDA approved Posicor despite findings from a congestive heart failure study suggesting that it might fatally disrupt heart rhythm (arrhythmia) when used with other drugs. The 2,400-patient clinical study found that 142 patients suddenly died after taking either Posicor or a placebo. The patients given Posicor died at a rate about 10% greater than those who took a comparator...MORE >>
Featured Articles on Posicor
Browse Books About Drug Litigation
The information you obtain at this site is not, nor is it intended to be, legal advice. You should consult an attorney for individual advice regarding your own situation.
